The FDA has approved an oral liquid therapy for the treatment of central diabetes insipidus in people of all ages, according to a press release. Desmopressin acetate (Desmoda, Eton Pharmaceuticals) is ...
Nocturia is fairly prevalent. A review by Bosch and Weiss [3] noted that most older men and women experience at least 1 void per night and on average two thirds of patients experience 2 or more voids ...
Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE® Nasal Spray 1.5 mg/mL listed ...
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug ...
The FDA has assigned a Prescription Drug User Fee Act target date of February 25, 2026 to the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ET-600 ...
15d
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...
Diabetes insipidus occurs when problems with antidiuretic hormone (ADH) cause the body to remove too much water. A synthetic version of ADH can help restore a person’s levels and treat some types of ...
DESMODA is the first and only FDA-approved desmopressin oral solution Commercial launch expected on March 9th DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results